İbrahim Hatemı

1.4k total citations
78 papers, 720 citations indexed

About

İbrahim Hatemı is a scholar working on Epidemiology, Surgery and Genetics. According to data from OpenAlex, İbrahim Hatemı has authored 78 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 21 papers in Surgery and 19 papers in Genetics. Recurrent topics in İbrahim Hatemı's work include Ocular Diseases and Behçet’s Syndrome (16 papers), Inflammatory Bowel Disease (16 papers) and Liver Disease Diagnosis and Treatment (14 papers). İbrahim Hatemı is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (16 papers), Inflammatory Bowel Disease (16 papers) and Liver Disease Diagnosis and Treatment (14 papers). İbrahim Hatemı collaborates with scholars based in Türkiye, United States and United Kingdom. İbrahim Hatemı's co-authors include Gülen Hatemi, Aykut Ferhat Çelık, Sinem Nihal Esatoğlu, Yusuf Erzın, Billur Canbakan, Hakan Şentürk, Abdullah Sonsuz, Gülşen Özbay, Veysel Tahan and Huriye Balcı and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of Hepatology.

In The Last Decade

İbrahim Hatemı

67 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
İbrahim Hatemı Türkiye 15 286 253 193 171 141 78 720
Androniki Bili United States 12 70 0.2× 48 0.2× 410 2.1× 61 0.4× 52 0.4× 17 619
Maria Grazia Anelli Italy 13 99 0.3× 54 0.2× 303 1.6× 43 0.3× 45 0.3× 31 584
Karin L. G. Svenson Sweden 12 86 0.3× 23 0.1× 321 1.7× 50 0.3× 54 0.4× 17 623
Sergio Morelli Italy 14 87 0.3× 37 0.1× 53 0.3× 144 0.8× 148 1.0× 29 541
Przemysław Kotyla Poland 15 81 0.3× 23 0.1× 242 1.3× 57 0.3× 40 0.3× 60 635
Kotaro Yokote Japan 8 111 0.4× 16 0.1× 31 0.2× 58 0.3× 220 1.6× 10 720
Yasumi Katsuta Japan 13 155 0.5× 33 0.1× 38 0.2× 79 0.5× 171 1.2× 42 407
Shinobu Waga Japan 14 30 0.1× 36 0.1× 118 0.6× 131 0.8× 79 0.6× 58 560
Shogo Takano Japan 6 134 0.5× 19 0.1× 63 0.3× 113 0.7× 83 0.6× 13 703
F. A. Spengel Germany 18 119 0.4× 45 0.2× 37 0.2× 247 1.4× 460 3.3× 55 842

Countries citing papers authored by İbrahim Hatemı

Since Specialization
Citations

This map shows the geographic impact of İbrahim Hatemı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İbrahim Hatemı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İbrahim Hatemı more than expected).

Fields of papers citing papers by İbrahim Hatemı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İbrahim Hatemı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İbrahim Hatemı. The network helps show where İbrahim Hatemı may publish in the future.

Co-authorship network of co-authors of İbrahim Hatemı

This figure shows the co-authorship network connecting the top 25 collaborators of İbrahim Hatemı. A scholar is included among the top collaborators of İbrahim Hatemı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İbrahim Hatemı. İbrahim Hatemı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Törüner, Murat, Haluk Tarık Kani, Vuslat Yılmaz, et al.. (2025). P1067 Comparison of AZA-Related Pancreatitis and AZA-Related GI Intolerance Based on Demographic Factors, Clinical Variables and HLA DQA1/DRB1 Alleles. Journal of Crohn s and Colitis. 19(Supplement_1). i1969–i1970.
2.
3.
Hatemı, İbrahim, et al.. (2024). Ascites does not accompany pleural effusion developing under dasatinib therapy in patients with CML-CP. SHILAP Revista de lepidopterología. 9(1). 39–43.
4.
Sonsuz, Abdullah, et al.. (2023). The Prevalence of Minimal Hepatic Encephalopathy in an Outpatient Hepatology Clinic. The Turkish Journal of Gastroenterology. 34(5). 560–567.
5.
Önal, Uğur, Rıdvan Karaali, Bilgül Mete, et al.. (2023). Comparison of Hospitalized COVID-19 Patients in Terms of Disease Course According to the Presence of Gastrointestinal Symptoms Before and After Admission. The Turkish Journal of Gastroenterology. 34(4). 322–331.
6.
Şahin, Serdar, Cem Sulu, Hande Mefkure Özkaya, et al.. (2023). Is There A Connection Between Primary Hypophysitis and Celiac Disease?. Experimental and Clinical Endocrinology & Diabetes. 132(1). 33–38. 1 indexed citations
7.
Özaslan, Ersan, Fulya Günşar, İbrahim Hatemı, et al.. (2023). Diagnosis and Treatment of Autoimmune Hepatitis: Questions, Answers, and Illustrative Cases: Endorsed by Autoimmune Liver Diseases Special Interest Group, Turkish Association for the Study of Liver. The Turkish Journal of Gastroenterology. 34(3). S1–S33. 3 indexed citations
8.
Copur, Mehmet Sitki, et al.. (2022). Recurrent colorectal carcinoma presenting with ileus due to small bowel metastases: A case report. SHILAP Revista de lepidopterología. 6(1). 100341–100341. 1 indexed citations
9.
Önal, Uğur, Murat Tuncer, İbrahim Hatemı, et al.. (2022). The Psychological Effects of COVID-19 Pandemic in Patients with Inflammatory Bowel Disease. The Turkish Journal of Gastroenterology. 33(5). 387–396. 1 indexed citations
10.
11.
Hacıoğlu, Ayşa, Şermin Börekçi, Melike Melikoğlu, et al.. (2021). Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination rates. Rheumatology International. 42(8). 1443–1451. 1 indexed citations
12.
Şahin, Serdar, et al.. (2020). The effect of somatostatin analogs and acromegaly on the upper gastrointestinal system. Pituitary. 24(2). 184–191. 1 indexed citations
13.
Demir, Nurhan, Mehmet Yürüyen, Hakan Yavuzer, et al.. (2017). Prevalence of fecal incontinence and associated risk factors in elderly outpatients: a cross-sectional study. Aging Clinical and Experimental Research. 29(6). 1165–1171. 14 indexed citations
14.
Salihoğlu, Ayşe, et al.. (2017). Fatal gastrointestinal bleeding and perforated duodenal ulcer: a rare complication of deferasirox in a patient with liver cirrhosis. Biomedical Research-tokyo. 28(12). 5620–5622. 2 indexed citations
15.
Canbakan, Billur, Özkan Alan, İbrahim Hatemı, et al.. (2017). Evaluation of non-invasive diagnostic methods as indicators of fibrosis in patients with nonalcoholic fatty liver disease. Biomedical Research-tokyo. 28(2). 565–570. 3 indexed citations
16.
Erzın, Yusuf, et al.. (2016). Demographic characteristics of chronic pancreatitis patients in the era of endosonography: Experience of a single tertiary referral center in Turkey. The Turkish Journal of Gastroenterology. 27(3). 284–289. 2 indexed citations
17.
Erzın, Yusuf, Nurhan Demir, Fatih Kantarcı, et al.. (2015). P565. The Increased Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients is not Related To Inflammatory Load. Journal of Crohn s and Colitis. 9(suppl 1). S363–S363. 3 indexed citations
18.
Erzın, Yusuf, Nurhan Demir, Fatih Kantarcı, et al.. (2015). P566. Efficacy and safety of vedolizumab with advancing age in patients with ulcerative colitis: Results from the GEMINI 1 study. Journal of Crohn s and Colitis. 9(suppl 1). S363–S364. 1 indexed citations
19.
Hatemı, İbrahim, et al.. (2012). Endosonography-assisted transmural endoscopic drainage of pancreatic pseudocysts: A single center experience. The Turkish Journal of Gastroenterology. 23(6). 741–746. 2 indexed citations
20.
Hatemı, İbrahim, et al.. (2011). A rare case of primary systemic amyloidosis presenting with hepatic failure. The Turkish Journal of Gastroenterology. 22(1). 113–114. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Androniki Bili Breakdown of academic impact, for papers by Maria Grazia Anelli Breakdown of academic impact, for papers by Karin L. G. Svenson Breakdown of academic impact, for papers by Sergio Morelli Breakdown of academic impact, for papers by Przemysław Kotyla Breakdown of academic impact, for papers by Kotaro Yokote Breakdown of academic impact, for papers by Yasumi Katsuta Breakdown of academic impact, for papers by Shinobu Waga Breakdown of academic impact, for papers by Shogo Takano Breakdown of academic impact, for papers by F. A. Spengel
Rankless by CCL
2026